Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus

被引：0
作者：
Yitong Wang
Bingfeng Xu
Lixia Zhu
Kun Lou
Yingli Chen
Xia Zhao
Qian Wang
Ling Xu
Xiaohui Guo
Linong Ji
Yimin Cui
Yi Fang
机构：
[1] Peking University People’s Hospital,Department of Pharmacy
[2] Peking University,Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical
[3] Xuzhou Medical College,Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy
[4] Anhui Fuyang Pharmaceutical Group Co.,Clinical Medicine Department
[5] Ltd.,Department of Endocrinology
[6] CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co.,Department of Pharmacy
[7] Ltd,Department of Endocrinology
[8] Peking University People’s Hospital,undefined
[9] Peking University First Hospital,undefined
[10] Shanghai University of Chinese Medicine,undefined
[11] Peking University First Hospital,undefined
来源：
Clinical Drug Investigation | 2017年 / 37卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1107 / 1115
页数：8
相关论文
共 50 条
  • [1] Pharmacokinetics and Preliminary Pharmacodynamics of Single- and Multiple-dose Lyophilized Recombinant Glucagon-like Peptide-1 Receptor Agonist (rE-4) in Chinese Patients with Type 2 Diabetes Mellitus
    Wang, Yitong
    Xu, Bingfeng
    Zhu, Lixia
    Lou, Kun
    Chen, Yingli
    Zhao, Xia
    Wang, Qian
    Xu, Ling
    Guo, Xiaohui
    Ji, Linong
    Cui, Yimin
    Fang, Yi
    CLINICAL DRUG INVESTIGATION, 2017, 37 (12) : 1107 - 1115
  • [2] Population pharmacokinetics of lyophilized recombinant glucagon-like peptide-1 receptor agonist (recombinant exendin-4, rE-4) in Chinese patients with type 2 diabetes mellitus
    Zang, Yan-Nan
    Zhang, Min-Jie
    Wang, Yi-Tong
    Wang, Chen
    Wang, Qian
    Zheng, Qing-Shan
    Ji, Li-Nong
    Guo, Wei
    Fang, Yi
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2017, 55 (08) : 650 - 658
  • [3] Pharmacokinetics, pharmacodynamics and tolerability of single dose of recombinant glucagon-like peptide-1 receptor agonist in healthy Chinese subjects
    Lu, Min
    Zhu, Li-Xia
    Yan, Ji-Ling
    Wang, Ying-Zheng
    Zhao, Xia
    Zhou, Ying
    Cui, Yi-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (05): : 8018 - 8024
  • [4] Initiating a Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes Mellitus
    Gavin, James R., III
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2012, 112 (01): : S16 - S21
  • [5] Design of Glucagon-Like Peptide-1 Receptor Agonist for Diabetes Mellitus from Traditional Chinese Medicine
    Tang, Hsin-Chieh
    Chen, Calvin Yu-Chian
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2014, 2014
  • [6] Albiglutide: A once-weekly glucagon-like peptide-1 receptor agonist for type 2 diabetes mellitus
    Davis, Portia N.
    Ndefo, Uche Anadu
    Oliver, Ashley
    Payton, Enryka
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (13) : 1097 - 1103
  • [7] Glucagon-like Peptide-1 Receptor Agonist Use in Patients With Liver Cirrhosis and Type 2 Diabetes
    Yen, Fu-Shun
    Hou, Ming-Chih
    Wei, James Cheng-Chung
    Shih, Ying-Hsiu
    Hsu, Chung Y.
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2024, 22 (06) : 1255 - 1264
  • [8] Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin
    Seino, Y.
    Takami, A.
    Boka, G.
    Niemoeller, E.
    Raccah, D.
    DIABETES OBESITY & METABOLISM, 2014, 16 (08) : 739 - 747
  • [9] Efficacy and tolerability of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus
    Harris, Kira B.
    McCarty, Delilah J.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 3 - 18
  • [10] Glucagon-like peptide-1 receptor agonist prescribing patterns in adolescents with type 2 diabetes
    Bensignor, Megan O.
    Wolf, Jack M.
    Rudser, Kyle D.
    Kelly, Aaron S.
    Arslanian, Silva
    DIABETES OBESITY & METABOLISM, 2022, 24 (07) : 1380 - 1384
12345